Article Information
History
- December 30, 2021.
Article Versions
- Version 1 (December 27, 2021 - 10:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Abhishek Nag1,
- Lawrence Middleton1,
- Ryan S. Dhindsa2,3,
- Dimitrios Vitsios1,
- Eleanor Wigmore1,
- Erik L. Allman1,
- Anna Reznichenko4,
- Keren Carss1,
- Katherine R. Smith1,
- Quanli Wang2,
- Benjamin Challis4,
- Dirk S. Paul1,
- Andrew R. Harper1 and
- Slavé Petrovski1,*
- 1Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 2Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, USA
- 3Department of Molecular and Human Genetics, Baylor College of Medicine and Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX 77030, USA
- 4Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- ↵*Corresponding author:
Slavé Petrovski, Vice-President, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom, Email: slav.petrovski{at}astrazeneca.com